Mental Disorder

A Promising Step Forward: Spravato’s Approval Offers Hope to MDD Sufferers with Acute Suicidal Ideation

A Promising Step Forward: Spravato’s Approval Offers Hope to MDD Sufferers with Acute Suicidal Ideation

In recent years, there has been a significant breakthrough in the field of mental health treatment, specifically for individuals battling Major Depressive Disorder (MDD) with acute suicidal ideation. Notably, Major Depressive Disorder (MDD) affects over 16 million adults annually in the United States, as reported by NCBI. The introduction of Spravato, a novel medication, has sparked hope and optimism among…

learn more